Shukaib Arslan
- Hematology top 10%
- Hematopoietic Stem Cell Transplantation 14
- Acute Myeloid Leukemia Research 8
- Chronic Myeloid Leukemia Treatments 5
- Transplantation top 10%
- Renal Transplantation Outcomes and Treatments 3
-
- Polyomavirus and related diseases 4
- CAR-T cell therapy research 3
-
- Myeloproliferative Neoplasms: Diagnosis and Treatment 3
-
- Acute Lymphoblastic Leukemia research 13
- Co-authors
- Monzr M. Al MalkiRyotaro NakamuraHaris AliGuido MarcucciStephen J. FormanIbrahim AldossAhmed AribiAnthony S. Stein
- Journals
- Blood (8 papers)American Journal of Hematology (4 papers)Biology of Blood and Marrow Transplantation (3 papers)
- Partner nations
- United StatesItalyGermany
In The Last Decade
Shukaib Arslan
22 papers receiving 224 citations
Peers
Comparison fields: 5 of 44
- Hematology 133
- Transplantation 23
- Infectious Diseases 75
- Oncology 64
- Genetics 23
Countries citing papers authored by Shukaib Arslan
This map shows the geographic impact of Shukaib Arslan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shukaib Arslan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shukaib Arslan more than expected).
Fields of papers citing papers by Shukaib Arslan
This network shows the impact of papers produced by Shukaib Arslan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shukaib Arslan. The network helps show where Shukaib Arslan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shukaib Arslan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2023 | 1 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 0 | |
| 6 | 2023 | 4 | |
| 7 | 2022 | 0 | |
| 8 | 2022 | 0 | |
| 9 | 2021 | 12 | |
| 10 | 2021 | 32 | |
| 11 | 2021 | 3 | |
| 12 | 2021 | 0 | |
| 13 | 2021 | 40 | |
| 14 | 2021 | 1 | |
| 15 | 2021 | 7 | |
| 16 | 2020 | 27 | |
| 17 | 2020 | 1 | |
| 18 | 2020 | 7 | |
| 19 | 2020 | 0 | |
| 20 | 2019 | 10 |
About Shukaib Arslan
Shukaib Arslan is a scholar working on Hematology, Transplantation and Genetics, having authored 30 papers that have together received 228 indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (14 papers), Acute Lymphoblastic Leukemia research (13 papers), Acute Myeloid Leukemia Research (8 papers), Chronic Myeloid Leukemia Treatments (5 papers), Polyomavirus and related diseases (4 papers), Renal Transplantation Outcomes and Treatments (3 papers), CAR-T cell therapy research (3 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers). The work is most often cited by research in Hematology (133 citations), Transplantation (23 citations) and Infectious Diseases (75 citations). Shukaib Arslan has collaborated with scholars based in United States, Italy and Germany. Frequent co-authors include Monzr M. Al Malki, Ryotaro Nakamura, Haris Ali, Guido Marcucci, Stephen J. Forman, Ibrahim Aldoss, Ahmed Aribi, Anthony S. Stein, Amandeep Salhotra and Sanjeet Dadwal. Their work appears in journals such as Blood, American Journal of Hematology, Biology of Blood and Marrow Transplantation, Transplantation and Cellular Therapy and Blood Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.